Greater Access to Affordable Pharmaceuticals Act

The Greater Access to Affordable Pharmaceuticals Act (S. 1225) aims to lower prescription drug costs by accelerating the entry of generic medications into the marketplace. The bill modifies federal regulations to prevent brand-name manufacturers from using multiple legal delays to block generic competition and establishes stricter timelines for bringing lower-cost alternatives to consumers. For everyday citizens, this legislation is designed to increase the availability of affordable medications by streamlining the FDA approval process and reducing the legal hurdles that often keep generic drugs off pharmacy shelves.